Tau S, Chamberlin MD, Yang H, Marotti JD, et al. Oxidative Phosphorylation is a Metabolic Vulnerability of Endocrine Therapy-Tolerant Persister Cells in ER+ Breast Cancer. Cancer Res 2025 Jan 9. doi: 10.1158/0008-5472.CAN-24-1204.
PMID: 39777474